{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:27:05Z","timestamp":1783488425700,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["CRSII5_170929"],"award-info":[{"award-number":["CRSII5_170929"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["F-41105-35-01"],"award-info":[{"award-number":["F-41105-35-01"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020012","name":"Institut f\u00fcr Tierpathologie, Freie Universit\u00e4t Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.200984","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:15:47Z","timestamp":1744629347000},"page":"200984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21"],"prefix":"10.1016","volume":"33","author":[{"given":"Fabian","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Kolibius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Gantenbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kipar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pl\u00fcckthun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.200984_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omton.2025.200984_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2025.200984_bib3","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200984_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.omton.2025.200984_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omton.2025.200984_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.omton.2025.200984_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100432","article-title":"Adenovirus vector-based vaccine for infectious diseases","volume":"42","author":"Sakurai","year":"2022","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.omton.2025.200984_bib8","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200984_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200984_bib10","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/jgm.553","article-title":"Adenovirus endocytosis","volume":"6","author":"Meier","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.omton.2025.200984_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-virology-092818-015550","article-title":"Adenovirus entry: from infection to immunity","volume":"6","author":"Greber","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib12","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/1873-3468.13691","article-title":"State-of-the-art human adenovirus vectorology for therapeutic approaches","volume":"593","author":"Gao","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2025.200984_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hum.2005.16.1","article-title":"Helper-dependent adenoviral vectors for gene therapy","volume":"16","author":"Palmer","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2025.200984_bib14","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/v2091886","article-title":"Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives","volume":"2","author":"Vetrini","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2025.200984_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omton.2025.200984_bib16","article-title":"Cloning and large-scale production of high-capacity adenoviral vectors based on the human adenovirus type 5","volume":"107","author":"Ehrke-Schulz","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omton.2025.200984_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.omtm.2021.01.002","article-title":"iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy","volume":"20","author":"Br\u00fccher","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.200984_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mt.6300031","article-title":"Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors","volume":"15","author":"Cerullo","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.200984_bib19","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2025.200984_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.omtm.2019.11.001","article-title":"Immunology of adenoviral vectors in cancer therapy","volume":"15","author":"Shaw","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.200984_bib21","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.1226625","article-title":"Coagulation factor X activates innate immunity to human species C adenovirus","volume":"338","author":"Doronin","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200984_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685218","article-title":"Lactoferrin retargets human adenoviruses to TLR4 to induce an abortive NLRP3-associated pyroptotic response in human phagocytes","volume":"12","author":"Ch\u00e9neau","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01850-21","article-title":"Adenovirus-alpha-defensin complexes induce NLRP3-associated maturation of human phagocytes via Toll-like receptor 4 engagement","volume":"96","author":"Eichholz","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/mt.2013.100","article-title":"FX and host defense evasion tactics by adenovirus","volume":"21","author":"Baker","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.200984_bib26","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib27","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1073\/pnas.89.7.2581","article-title":"Adenovirus as an expression vector in muscle cells in vivo","volume":"89","author":"Quantin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200984_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2017.10.005","article-title":"Retargeted and detargeted adenovirus for gene delivery to the muscle","volume":"514","author":"Nguyen","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.omton.2025.200984_bib29","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.4049\/jimmunol.162.11.6378","article-title":"Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector","volume":"162","author":"Tillman","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib30","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1099\/vir.0.008342-0","article-title":"Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN","volume":"90","author":"Adams","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib31","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.1073\/pnas.1806314115","article-title":"TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination","volume":"115","author":"Bottermann","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200984_bib32","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.V122.21.2278.2278","article-title":"Novel tumor-targeted, engineered IL-2 variant (IL2v)-based immunocytokines for immunotherapy of cancer","volume":"122","author":"Klein","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200984_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1913791","article-title":"Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy","volume":"13","author":"Waldhauer","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.omton.2025.200984_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156628","article-title":"A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells","volume":"132","author":"Holcomb","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.200984_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.it.2016.06.001","article-title":"IL-21 and T cell differentiation: consider the context","volume":"37","author":"Tian","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2482","article-title":"Interleukin 21: combination strategies for cancer therapy","volume":"7","author":"Skak","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2025.200984_bib37","first-page":"11","article-title":"Managing toxicities of high-dose interleukin-2","volume":"16","author":"Schwartz","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.omton.2025.200984_bib38","doi-asserted-by":"crossref","DOI":"10.4161\/onci.24522","article-title":"IL-21 in cancer immunotherapy: At the right place at the right time","volume":"2","author":"Santegoets","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omton.2025.200984_bib39","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.1073\/pnas.1213653110","article-title":"Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters","volume":"110","author":"Dreier","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200984_bib40","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/acs.bioconjchem.2c00346","article-title":"Modular adapters utilizing binders of different molecular types expand cell-targeting options for adenovirus gene delivery","volume":"33","author":"Freitag","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omton.2025.200984_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.omtm.2023.02.012","article-title":"Targeted adenovirus-mediated transduction of human T cells in vitro and in vivo","volume":"29","author":"Freitag","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.200984_bib42","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.ymthe.2023.08.018","article-title":"FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment","volume":"31","author":"Hartmann","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.200984_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017925118","article-title":"The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody","volume":"118","author":"Smith","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200984_bib44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41467-017-02707-6","article-title":"Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control","volume":"9","author":"Schmid","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.200984_bib45","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1128\/JVI.01893-13","article-title":"Role of DC-SIGN in Lassa virus entry into human dendritic cells","volume":"87","author":"Goncalves","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib46","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/ijc.25810","article-title":"Ag-bearing liposomes engrafted with peptides that interact with CD11c\/CD18 induce potent Ag-specific and antitumor immunity","volume":"129","author":"Faham","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2025.200984_bib47","unstructured":"Britton, W., and Demangel, C. (2004). Composition and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments. US patent 20040146948A1."},{"key":"10.1016\/j.omton.2025.200984_bib48","unstructured":"Dighe, R.R., and Sinha, S. (2020). Dendritic cells-targeting vaccine. US patent 20200347138A1."},{"key":"10.1016\/j.omton.2025.200984_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2025.200984_bib50","unstructured":"Zhang, Y., Yu, G., and Zhu, W. (2017). Anti-CD40 antibodies and methods of use. US patent 9,676,861 B2."},{"key":"10.1016\/j.omton.2025.200984_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1189\/jlb.0306171","article-title":"The secretion of HMGB1 is required for the migration of maturing dendritic cells","volume":"81","author":"Dumitriu","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.omton.2025.200984_bib52","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.4049\/jimmunol.168.5.2118","article-title":"The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells","volume":"168","author":"Engering","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib53","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3389\/fimmu.2017.01866","article-title":"beta(2) Integrins as regulators of dendritic cell, monocyte, and macrophage function","volume":"8","author":"Schittenhelm","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","article-title":"The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing","volume":"375","author":"Jiang","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.200984_bib55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omton.2025.200984_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.765034","article-title":"The mannose receptor: from endocytic receptor and biomarker to regulator of (meta)inflammation","volume":"12","author":"van der Zande","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","article-title":"Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200984_bib58","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cellsig.2010.03.018","article-title":"C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity","volume":"22","author":"Svajger","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.omton.2025.200984_bib59","series-title":"Chapter 34: Mannose-fucose recognition by DC-SIGN","first-page":"673","author":"Geurtsen","year":"2010"},{"key":"10.1016\/j.omton.2025.200984_bib60","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1128\/JVI.00651-15","article-title":"Molecular mechanism for LAMP1 recognition by Lassa virus","volume":"89","author":"Cohen-Dvashi","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006337","article-title":"Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses","volume":"13","author":"Israeli","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omton.2025.200984_bib62","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1083\/jcb.120.4.1031","article-title":"The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b\/CD18) for four distinct adhesion ligands","volume":"120","author":"Diamond","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omton.2025.200984_bib63","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/eji.200425914","article-title":"Interaction of ICAM-1 with beta 2-integrin CD11c\/CD18: characterization of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1","volume":"35","author":"Frick","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib64","first-page":"331","article-title":"Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research","volume":"3","author":"Marraco","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib65","first-page":"85","article-title":"Murine and human model systems for the study of dendritic cell immunobiology","volume":"35","author":"Hargadon","year":"2016","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006914","article-title":"Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor","volume":"14","author":"Stichling","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omton.2025.200984_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omton.2025.200984_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00542-20","article-title":"Lactoferrin-hexon interactions mediate CAR-independent adenovirus infection of human respiratory cells","volume":"94","author":"Persson","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib69","series-title":"The Laboratory Mouse","first-page":"709","article-title":"Routes of Administration","author":"Hirota","year":"2012"},{"key":"10.1016\/j.omton.2025.200984_bib70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jim.2007.08.004","article-title":"Hock immunization: a humane alternative to mouse footpad injections","volume":"328","author":"Kamala","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.omton.2025.200984_bib71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12917-018-1659-x","article-title":"Comparison of hock- and footpad-injection as a prostate adenocarcinoma model in rats","volume":"14","author":"Richter","year":"2018","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.omton.2025.200984_bib72","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1095\/biolreprod.115.130856","article-title":"The family secrets of avian egg-specific ovalbumin and its related proteins Y and X","volume":"93","author":"Da Silva","year":"2015","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.omton.2025.200984_bib73","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4049\/jimmunol.1202797","article-title":"NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge","volume":"192","author":"Bouwer","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib74","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s43018-023-00600-4","article-title":"CD8(+) T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis","volume":"4","author":"Lerner","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2025.200984_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0025-5564(81)90036-5","article-title":"Receptor clustering on a cell-surface. III. Theory of receptor cross-linking by multivalent ligands: description by ligand states","volume":"53","author":"Perelson","year":"1981","journal-title":"Math. Biosci."},{"key":"10.1016\/j.omton.2025.200984_bib76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2006.05.035","article-title":"NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells","volume":"126","author":"Savina","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200984_bib77","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1873-3468.13731","article-title":"Retargeting adenoviruses for therapeutic applications and vaccines","volume":"594","author":"Barry","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2025.200984_bib78","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/jvi.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"Krasnykh","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib79","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/nbt1196-1574","article-title":"Targeted gene delivery by tropism-modified adenoviral vectors","volume":"14","author":"Douglas","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2025.200984_bib80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.vaccine.2005.08.038","article-title":"Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens","volume":"24","author":"Maguire","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.omton.2025.200984_bib81","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4161\/cbt.4.3.1499","article-title":"High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN","volume":"4","author":"Korokhov","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.omton.2025.200984_bib82","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s13311-018-0650-3","article-title":"A dendritic cell-targeted adenoviral vector facilitates adaptive immune response against human glioma antigen (CMV-IE) and prolongs survival in a human glioma tumor model","volume":"15","author":"Kim","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omton.2025.200984_bib83","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/S0264-410X(03)00050-1","article-title":"CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation","volume":"21","author":"Brandao","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.omton.2025.200984_bib84","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ymthe.2004.02.006","article-title":"Enhanced gene transfer to mouse dendritic cells using adenovioral vectors coated with a novel adapter molecule","volume":"9","author":"Pereboev","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.200984_bib85","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1158\/0008-5472.CAN-11-0804","article-title":"Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine","volume":"71","author":"Hangalapura","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.200984_bib86","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1089\/hum.2009.202","article-title":"CD40-targeted recombinant adenovirus significantly enhances the efficacy of antitumor vaccines based on dendritic cells and B cells","volume":"21","author":"Kim","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2025.200984_bib87","first-page":"7913","article-title":"Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells","volume":"61","author":"Okada","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.200984_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1349-7006.2001.tb01098.x","article-title":"Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells","volume":"92","author":"Asada-Mikami","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.omton.2025.200984_bib89","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","article-title":"The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria","volume":"11","author":"Kell","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib90","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2020.08.003","article-title":"ZVex\u2122, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities","volume":"38","author":"Leleux","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.omton.2025.200984_bib91","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41598-019-40071-1","article-title":"Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity","volume":"9","author":"Rossi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.200984_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007430","article-title":"Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells","volume":"14","author":"Schaeffer","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omton.2025.200984_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.200984_bib94","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/infdis\/jiaa121","article-title":"A randomized dose-escalating phase I trial of a replication-deficient lymphocytic choriomeningitis virus vector-based vaccine against human cytomegalovirus","volume":"225","author":"Schwendinger","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omton.2025.200984_bib95","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/vaccines11061115","article-title":"Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report","volume":"11","author":"Lin","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.omton.2025.200984_bib96","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/hematolrep14040050","article-title":"COVID-19 adenoviral vaccine-induced immune thrombotic thrombocytopenia (VITT), COVID-19-related thrombosis, and the thrombotic thrombocytopenic syndromes","volume":"14","author":"Allas","year":"2022","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.omton.2025.200984_bib97","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/1074-7613(94)90090-6","article-title":"Efficiency of MHC class I antigen processing: a quantitative analysis","volume":"1","author":"Villanueva","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200984_bib98","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1523-1747.2003.12603.x","article-title":"Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo","volume":"121","author":"Brandt","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.omton.2025.200984_bib99","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2013.02.011","article-title":"The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells","volume":"38","author":"Wan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.200984_bib100","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.7150\/thno.56406","article-title":"Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk\/IL-21 axis","volume":"11","author":"Gou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.omton.2025.200984_bib101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/gt.2014.12","article-title":"Tumor-associated antigen\/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma","volume":"21","author":"Aravindaram","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2025.200984_bib102","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/intimm\/dxs112","article-title":"Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response","volume":"25","author":"Tenbusch","year":"2013","journal-title":"Int. Immunol."},{"key":"10.1016\/j.omton.2025.200984_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3575","article-title":"Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy","volume":"12","author":"Francis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2025.200984_bib104","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","article-title":"Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo","volume":"78","author":"Muruve","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200984_bib105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.12659\/MSM.896951","article-title":"Culture and identification of mouse bone marrow-derived dendritic cells and their capability to induce T lymphocyte proliferation","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.omton.2025.200984_bib106","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.84.10.3405","article-title":"Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma-cells in parallel with enhanced expression of class I major histocompatibility complex antigens","volume":"84","author":"Taniguchi","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:03:14Z","timestamp":1762657394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950329925000530"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.200984","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.200984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200984"}}